Advances In Reimbursement: Prostate Cancer AI Mapping Receives CPT Code

 
• By Hannah Daniel

Avenda’s chief operating officer Brit Berry-Pusey spoke to Medtech Insight about the company’s CPT III code for its prostate cancer mapping AI and how regulatory bodies can align to support innovators.

• Source: Shutterstock

More from Policy & Regulation

More from Medtech Insight